跳至主要内容
临床试验/NCT03393715
NCT03393715已完成4 期

Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes

Yaounde Central Hospital0 个研究点目标入组 20 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
主要终点
24-hour blood pressure profile

研究概览

简要总结

We assessed the influence of time of administration of ACE inhibitors on circadian blood pressure control in sub Saharan type 2 diabetes patients with stage 1 hypertension over 56 days as first line treatment.

详细描述

Background: Renin-angiotensin system antagonists represent the mainstay of blood pressure (BP) lowering treatment options in people with diabetes. ACE inhibitors have a long half-life and offer the advantage of a single daily dose, usually empirically taken in the morning.

Objective

We assessed the influence of time of administration of ACE inhibitors on circadian BP control in type 2 diabetes (T2D) patients with stage 1 hypertension.

Methods: Twenty T2D patients (9 being women) with a mean age of 58.7 years, diagnosed with stage 1 of hypertension and naive to BP lowering medications, were included. They were randomly allocated to receive perindopril 10 mg/day as a monotherapy either in the morning or in the evening for 28 days, with crossover without washout period on day 29th and additional 28 days follow-up. A 24-hour ambulatory BP monitoring (ABPM) was performed at baseline, days 28 and 56.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes
  • Grade 1 hypertension
  • Informed consent

排除标准

  • estimated creatinine clearance≤ 60ml/min
  • White coat hypertension after initial 24 hour ABPM
  • Previous antihypertensive treatment
  • Pregnant women
  • Individuals working during the night
  • Hyperkalemia

研究组 & 干预措施

Perindopril morning

Experimental

10 mg of perindopril oral tablet once daily in the morning for 56 days

干预措施: Perindopril Oral Tablet (Drug)

Perindopril evening

Active Comparator

10 mg of perindopril oral tablet once daily in the evening for 56 days

干预措施: Perindopril Oral Tablet (Drug)

结局指标

主要结局

24-hour blood pressure profile

时间窗: 56 days

Overall blood pressure control

次要结局

  • Night time blood pressure dip(56 days)

研究者

发起方
Yaounde Central Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Sobngwi Eugene

Professor of Endocrinology and Diabetes

Yaounde Central Hospital

相似试验